Research Article

Chronic Administration of Tadalafil Improves the Symptoms of Patients with Amicrobic MAGI: An Open Study

Table 1

Structured Interview about Male Accessory Gland Infections (SI-MAGI).
(a) Urinary disorders (levels of severity: absent: 0; mild: 1–6; moderate: 7–12; severe: 13–18)

Question0123

1Nocturia0 times1 time2 times>2 times
2Urinary frequencyAbsentEvery 2 hours<2 hoursEvery 1 hour
3Strength of the urinary streamRegularOccasional difficultyConstant difficultyConstant difficulty and
weakening voided urine
4Quality of urinary streamRegularWith intervalsIrregular and continuousPost micturition drip
5Failure to empty the bladderAbsentEpisodicFrequent (>50%)Constant
6Duration of symptomsAbsent<1 month1–3 months>3 months

(b) Spontaneous and/or ejaculatory pain or discomfort (levels of severity: absent: 0; mild: 1–8; moderate: 9–16; severe: 17–24)

Item0123

1Perineal areaAbsentOccasional and/or
<3 months
>50% or >3 monthsConstant and by more than
3 months
2Inguinal areaAbsentOccasional and/or
<3 months
>50% or >3 monthsConstant and by more than
3 months
3Scrotal areaAbsentOccasional and/or
<3 months
>50% or >3 monthsConstant and by more than
3 months
4Penile areaAbsentOccasional and/or
<3 months
>50% or >3 monthsConstant and by more than
3 months
5Coccyx areaAbsentOccasional and/or
<3 months
>50% or >3 monthsConstant and by more than
3 months
6Suprapubic areaAbsentOccasional and/or
<3 months
>50% or >3 monthsConstant and by more than
3 months
7Irregular bowel and/or diarrhea
and/or hematochezia
AbsentPresence of <1 symptom
and/or sign
Presence of 2 symptoms/signsPresence of 3 symptoms/signs
8Duration of symptomsAbsent<1 month1–3 months>3 months

(c) Sexual function (levels of severity: absent: 0; mild: 1–11; moderate: 12–22; severe: 23–33)

Item0123

1Reduction of libidoAbsentOccasional and/or >3 months>50% and/or >3 monthsConstant and/or >3 months
2Erectile dysfunction (achievement)AbsentOccasional and/or >3 months>50% and/or >3 monthsConstant and/or >3 months
3Erectile dysfunction (maintenance)AbsentOccasional and/or >3 months>50% and/or >3 monthsConstant and/or >3 months
4Difficulties in the second reportAbsentOccasional and/or >3 months>50% and/or >3 monthsConstant and/or >3 months
5Premature ejaculationAbsentOccasional and/or >3 months>50% and/or >3 monthsConstant and/or >3 months
6Delayed ejaculationAbsentOccasional and/or >3 months>50% and/or >3 monthsConstant and/or >3 months
7Alteration of the macroscopic character of the ejaculateAbsentOne of the following: stringy, yellow or red-brown, volume reductionTwo of the following: stringy, yellow or red-brown, volume reductionAll of the following: stringy, yellow or red-brown, volume reduction
8Painful ejaculationAbsentEpisodicFrequent (>50%)Constant
9Ejaculate emissionAbsentOccasionally weakenedWeakened >50% of the timeIncreasingly weakened
10ProstatorrheaAbsentEpisodicFrequent (>50%)Constant
11HyperspermiaAbsentEpisodicFrequent (>50%)Constant

(d) Quality of life (levels of severity: absent: 0; mild: 1–5; moderate: 6–10; severe: 11–15)

Item0123

1Quality of life associated with
the onset of symptoms
Like beforeSatisfactions and failuresFrustrating and/or
use of psychoanalysis
Terrible with recourse to
psychoanalysis and/or drugs
2Life changes associated with
the onset of symptoms
AbsentFewSeveralSeveral and important
3School or work days lost01 day per month2 days a month> 2 days per month
4Quality of married life since it
began a diagnostic evaluation
and/or treatment
Like beforeSatisfactions and failuresFrustrating and/or use
of psychoanalysis
Terrible with recourse to
psychoanalysis and/or drugs
5Infertility duration<1 year1-2 years3-4 years>4 years

(e) Ultrasound criteria of MAGI

Prostatitis is suspected in the presence of >2 of the following ultrasonographic signs:
(1) asymmetry of the gland volume; (2) areas of low echogenicity; (3) areas of high echogenicity; (4) dilatation of periprostatic venous plexus; (5) single or multiple internal similar cystitis areas; and (6) area/s of moderate increased of vascularity (focal or multiple).

Vesiculitis is suspected in the presence of >2 of the following ultrasonographic signs:
(1) increase (>14 mm) anteroposterior diameter mono or bilateral; (2) asymmetry > 2.5 mm (normal 7–14 mm) compared to the contralateral vesicle; (3) reduced (<7 mm) anteroposterior diameter mono or bilateral; (4) glandular epithelium thickened and/or calcified; (5) polycyclic areas separated by hyperechoic septa in one or both vesicles; (6) fundus/body ratio > 2.5; (7) fundus/body ratio < 1; and (8) anteroposterior diameter unchanged after recent immediately ejaculation.

Epididymitis is suspected in the presence of >2 of the following ultrasonographic signs:
(1) increase in size of the head (craniocaudal diameter > 12 mm) and/or of the tail (craniocaudal diameter > 6 mm) (finding single or bilateral); (2) presence of multiple microcystis in the head and/or tail (finding single or bilateral); (3) low echogenicity or high echogenicity mono or bilateral; (4) large hydrocele mono or bilateral; (5) enlargement in the superior part of the cephalic tract and the superior/inferior part ratio > 1; and (6) unchanged anteroposterior diameter of tail after ejaculation.